Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Pediatric Dermatology|August 15, 2017
Study of Cognitive Function in Children Treated with Propranolol for Infantile HemangiomaNieves González-Llorente, Isabel Del Olmo-Benito, Natalia Muñoz-Ollero, et al.
The Journal of Dermatology|April 28, 2018
Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinomaAntonio Tejera-Vaquerizo, Ignacio García-Doval, Beatriz Llombart, et al.
Annals of the Rheumatic Diseases|June 17, 2010
Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonistsIgnacio García-Doval, Beatriz Pérez-Zafrilla, Miguel Angel Descalzo, et al.
JAMA Dermatology|December 18, 2024
Interobserver and Intraobserver Agreement on the Treatment of Infantile HemangiomasMaría Colmenero-Sendra, Javier Del Boz-González, Mercè Grau-Pérez, et al.
Orphanet Journal of Rare Diseases|April 24, 2013
Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disordersPaula Davila-Seijo, Angela Hernández-Martín, Evanina Morcillo-Makow, et al.
Pediatric Dermatology|October 11, 2021
Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma RegistryJuan Torre-Castro, Teresa Estrach, Yeray Peñate, et al.
Contact Dermatitis|September 30, 2017
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective studyPedro Mercader-García, María A Pastor-Nieto, Ignacio García-Doval, et al.
The Journal of Dermatological Treatment|October 12, 2018
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter studyAndrea Montes-Torres, Gloria Aparicio, Raquel Rivera, et al.
The Journal of Dermatological Treatment|September 15, 2015
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohortIgnacio García-Doval, Beatriz Pérez-Zafrilla, Carlos Ferrandiz, et al.
The Journal of Investigative Dermatology|September 29, 2016
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM RegistryPaula Dávila-Seijo, Esteban Dauden, M A Descalzo, et al.
Pageof 5